Abbott Laboratories Share Price

Equities

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 21:00:01 14/06/2024 BST 5-day change 1st Jan Change
103.7 USD +0.22% Intraday chart for Abbott Laboratories -3.63% -5.81%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 41.72B 3,290B Sales 2025 * 44.73B 3,527B Capitalization 180B 14,222B
Net income 2024 * 5.98B 472B Net income 2025 * 7.17B 565B EV / Sales 2024 * 4.45 x
Net Debt 2024 * 5.47B 431B Net Debt 2025 * 112M 8.84B EV / Sales 2025 * 4.03 x
P/E ratio 2024 *
30 x
P/E ratio 2025 *
25.8 x
Employees 114,000
Yield 2024 *
2.11%
Yield 2025 *
2.27%
Free-Float 86.96%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.22%
1 week-3.63%
Current month+1.46%
1 month-0.87%
3 months-10.23%
6 months-3.36%
Current year-5.81%
More quotes
1 week
102.43
Extreme 102.43
108.98
1 month
100.64
Extreme 100.64
108.98
Current year
100.64
Extreme 100.64
121.64
1 year
89.67
Extreme 89.674
121.64
3 years
89.67
Extreme 89.674
142.60
5 years
61.61
Extreme 61.61
142.60
10 years
36.00
Extreme 36
142.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 31/12/14
Director of Finance/CFO 51 31/12/96
Chief Tech/Sci/R&D Officer - 31/12/89
Members of the board TitleAgeSince
Director/Board Member 69 15/02/17
Director/Board Member 63 28/06/17
Director/Board Member 65 08/12/11
More insiders
Date Price Change Volume
14/06/24 103.7 +0.22% 3,683,145
13/06/24 103.4 -0.89% 4,719,494
12/06/24 104.4 -1.35% 4,569,029
11/06/24 105.8 -1.56% 7,536,183
10/06/24 107.5 -0.08% 8,556,495

Delayed Quote Nyse, June 14, 2024 at 09:00 pm

More quotes
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
103.7 USD
Average target price
125.4 USD
Spread / Average Target
+20.92%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW